CMH Wealth Management LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 10,724 shares of the semiconductor company's stock, valued at approximately $5,498,000.
Several other large investors have also modified their holdings of the business. GAMMA Investing LLC lifted its stake in Synopsys by 54,286.0% during the 1st quarter. GAMMA Investing LLC now owns 1,196,492 shares of the semiconductor company's stock worth $513,116,000 after acquiring an additional 1,194,292 shares in the last quarter. Nuveen LLC acquired a new position in Synopsys during the 1st quarter worth about $341,480,000. Pictet Asset Management Holding SA lifted its stake in Synopsys by 38.3% during the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock worth $1,043,518,000 after acquiring an additional 673,837 shares in the last quarter. Generation Investment Management LLP acquired a new position in Synopsys during the 1st quarter worth about $240,491,000. Finally, Vanguard Group Inc. lifted its stake in Synopsys by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company's stock worth $6,359,747,000 after acquiring an additional 346,994 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.
Insiders Place Their Bets
In other Synopsys news, Director Robert G. Painter acquired 350 shares of the stock in a transaction dated Thursday, September 11th. The stock was acquired at an average price of $425.44 per share, with a total value of $148,904.00. Following the completion of the transaction, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. This trade represents a 18.03% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the sale, the chief accounting officer directly owned 20,520 shares of the company's stock, valued at approximately $10,278,468. This represents a 32.48% decrease in their position. The disclosure for this sale can be found here. Insiders sold 30,894 shares of company stock worth $16,760,783 in the last three months. Company insiders own 0.62% of the company's stock.
Synopsys Price Performance
Shares of NASDAQ SNPS traded down $23.69 during trading on Tuesday, reaching $491.10. The company had a trading volume of 2,683,545 shares, compared to its average volume of 1,748,005. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The stock has a market capitalization of $91.22 billion, a PE ratio of 38.56, a price-to-earnings-growth ratio of 5.60 and a beta of 1.14. The stock has a 50-day moving average price of $579.33 and a two-hundred day moving average price of $507.65. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on SNPS. Wall Street Zen lowered Synopsys from a "hold" rating to a "sell" rating in a research report on Saturday, September 13th. Wells Fargo & Company dropped their price target on Synopsys from $630.00 to $550.00 and set an "equal weight" rating on the stock in a research note on Wednesday, September 10th. Citigroup downgraded Synopsys from a "neutral" rating to an "underperform" rating in a research note on Wednesday, September 10th. Mizuho decreased their price objective on Synopsys from $700.00 to $600.00 and set an "outperform" rating for the company in a research report on Thursday, September 11th. Finally, JPMorgan Chase & Co. decreased their price objective on Synopsys from $685.00 to $600.00 and set an "overweight" rating for the company in a research report on Wednesday, September 10th. Eleven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $585.33.
Check Out Our Latest Stock Report on SNPS
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.